Full Committee Hearing FDA User Fee Agreements: Strengthening FDA and the Medical Products Industry for the Benefit of Patients

Date: Thursday, March 29, 2012 Time: 10:00 AM Location: 216 Hart Senate Office Building

Open in New Window

Witnesses

Panel I

  1. Janet Woodcock, M.D.
    Director
    Center for Drug Evaluation and Research, Food and Drug Administration
    Silver Spring, MD
  2. Jeffrey Shuren, M.D., J.D.
    Director
    Center for Devices and Radiological Health, Food and Drug Administration
    Silver Spring, MD

Panel II

  1. David Wheadon, M.D.
    Senior Vice President of Scientific and Regulatory Affairs
    Pharmaceutical Research and Manufacturers of America
    Washington, DC
  2. Sara Radcliffe
    Executive Vice President
    Health, Biotechnology Industry Organization
    Washington, DC
  3. David R. Gaugh, R.Ph.
    Vice President for Regulatory Affairs
    Generic Pharmaceutical Association
    Washington, DC
  4. David Nexon, Ph.D.
    Senior Executive Vice President
    Advanced Medical Technology Association
    Washington, DC
  5. Allan Coukell, BScPharm
    Director of Medical Programs, The Pew Charitable Trusts
    Washington, DC

Transcripts

Related Photos

Chairman Harkin Sen. Enzi, Ranking Member Sen. Burr Sen. Enzi and Sen. Harkin Sen. Murray Sen. Mikulski Sen. Roberts Janet Woodcock Jeffrey Shuren The first panelists